Holds one active US DMF for testosterone cypionate, filing since 2017. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for testosterone cypionate, filing since 2017. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for testosterone cypionate, filing since 2025. Its 2023 FDA inspection closed as NAI.
Holds one active US DMF for testosterone cypionate, filing since 2025. Its 2021 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for testosterone cypionate, filing since 1980.
Holds one active US DMF for testosterone cypionate, filing since 2018.
Registered with SFDA (Saudi Arabia) for testosterone cypionate. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free